Sally C. Pipes

Commentary

In the rush to hold insurers to account, don’t forget about hospitals

When asked to account for the skyrocketing cost of health coverage before two House committees last Thursday, the chief executives of five of America’s largest health insurance companies pointed fingers. Don’t look at us, they said. Look at hospitals and drugmakers. Read the op-ed here.
Commentary

Sorry, but single-payer won’t fix American health care

Affordability is becoming the watchword for Republicans and Democrats alike this election year. Progressives in Senate races from Maine to Illinois to Minnesota are putting Medicare for All at the center of their agenda for making health care affordable. Polling shows that some two-thirds of Americans support the policy. The ...
Commentary

Open, Competitive Market Will Make Trump’s Health Plan Great

President Trump’s recently released Great Healthcare Plan offers several welcome reforms. It endeavors to put patients first by fostering greater price transparency and taking steps to lower health insurance premiums. Its approach to prescription drug policy is a bit more mixed. Read the op-ed here.
Commentary

CMS Officials Are Undermining Trump’s Push For Affordable Drugs

Officials at the Centers for Medicare and Medicaid Services just undermined President Trump’s efforts to make prescription drugs more affordable. Earlier this week, CMS announced the next 15 medicines that will face price caps under Medicare’s Drug Price “Negotiation” Program, a core component of the Inflation Reduction Act signed into ...
Commentary

The ‘Medicare-For-All’ Delusion

As Congress looks for ways to bring down the cost of insurance, a growing number of Democrats are pushing to get rid of insurance altogether and make the federal government the sole funder of health care in this country. Several progressive Senate candidates have put Medicare for All at the ...
Commentary

Proposed patent tax offers a dangerous ‘solution’ to a non-existent problem

US Commerce Secretary Howard Lutnick believes taxpayers are getting short-changed by America’s patent system. Last year, he argued that the federal government should be entitled to 50% of the revenue universities earn from licensing the patented discoveries they’ve made with help from federally funded research grants. Lutnick is deeply mistaken. ...
Commentary

No Accountability as Insurers Profit From Public Programs

Executives from the nation’s largest health insurers are set to testify before Congress soon in a hearing on healthcare affordability. It’s about time. From Medicare Advantage to Obamacare exchanges to prescription drug benefits, insurers have been extracting ever-greater amounts of public funds while passing costs and risk on to patients ...
Commentary

Red tape is strangling rural health care. It’s time to cut it

Rural America is running out of doctors. According to a new report from the Commonwealth Fund, 43 million Americans now live in rural communities facing a shortage of primary care providers. This shortage isn’t new. It’s been reality for rural America for decades. And it helps explain why patients there ...
Commentary

Alexis Wilkins Interview Of Sally Pipes

PRI’s Sally Pipes discusses health care policy and the threat of single payer with podcast host Alexis Wilkins. Listen to the entire podcast here. 
Commentary

Enhanced Obamacare subsidies are gone. They deserve to stay that way

House Ways and Means Committee Chairman Jason Smith (R-MO) took to the chamber’s floor last week to voice his opposition to legislation that would extend the pandemic-era enhanced premium subsidies for Obamacare plans for three years. Unfortunately, his wise counsel fell on deaf ears, as all Democrats and 17 Republicans ...
Commentary

In the rush to hold insurers to account, don’t forget about hospitals

When asked to account for the skyrocketing cost of health coverage before two House committees last Thursday, the chief executives of five of America’s largest health insurance companies pointed fingers. Don’t look at us, they said. Look at hospitals and drugmakers. Read the op-ed here.
Commentary

Sorry, but single-payer won’t fix American health care

Affordability is becoming the watchword for Republicans and Democrats alike this election year. Progressives in Senate races from Maine to Illinois to Minnesota are putting Medicare for All at the center of their agenda for making health care affordable. Polling shows that some two-thirds of Americans support the policy. The ...
Commentary

Open, Competitive Market Will Make Trump’s Health Plan Great

President Trump’s recently released Great Healthcare Plan offers several welcome reforms. It endeavors to put patients first by fostering greater price transparency and taking steps to lower health insurance premiums. Its approach to prescription drug policy is a bit more mixed. Read the op-ed here.
Commentary

CMS Officials Are Undermining Trump’s Push For Affordable Drugs

Officials at the Centers for Medicare and Medicaid Services just undermined President Trump’s efforts to make prescription drugs more affordable. Earlier this week, CMS announced the next 15 medicines that will face price caps under Medicare’s Drug Price “Negotiation” Program, a core component of the Inflation Reduction Act signed into ...
Commentary

The ‘Medicare-For-All’ Delusion

As Congress looks for ways to bring down the cost of insurance, a growing number of Democrats are pushing to get rid of insurance altogether and make the federal government the sole funder of health care in this country. Several progressive Senate candidates have put Medicare for All at the ...
Commentary

Proposed patent tax offers a dangerous ‘solution’ to a non-existent problem

US Commerce Secretary Howard Lutnick believes taxpayers are getting short-changed by America’s patent system. Last year, he argued that the federal government should be entitled to 50% of the revenue universities earn from licensing the patented discoveries they’ve made with help from federally funded research grants. Lutnick is deeply mistaken. ...
Commentary

No Accountability as Insurers Profit From Public Programs

Executives from the nation’s largest health insurers are set to testify before Congress soon in a hearing on healthcare affordability. It’s about time. From Medicare Advantage to Obamacare exchanges to prescription drug benefits, insurers have been extracting ever-greater amounts of public funds while passing costs and risk on to patients ...
Commentary

Red tape is strangling rural health care. It’s time to cut it

Rural America is running out of doctors. According to a new report from the Commonwealth Fund, 43 million Americans now live in rural communities facing a shortage of primary care providers. This shortage isn’t new. It’s been reality for rural America for decades. And it helps explain why patients there ...
Commentary

Alexis Wilkins Interview Of Sally Pipes

PRI’s Sally Pipes discusses health care policy and the threat of single payer with podcast host Alexis Wilkins. Listen to the entire podcast here. 
Commentary

Enhanced Obamacare subsidies are gone. They deserve to stay that way

House Ways and Means Committee Chairman Jason Smith (R-MO) took to the chamber’s floor last week to voice his opposition to legislation that would extend the pandemic-era enhanced premium subsidies for Obamacare plans for three years. Unfortunately, his wise counsel fell on deaf ears, as all Democrats and 17 Republicans ...
Scroll to Top